期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 380, 期 15, 页码 1483-1485出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc1813435
关键词
-
资金
- Janssen Research and Development
A preliminary analysis of a trial involving participants with brain amyloid deposition who are at risk for dementia due to Alzheimer's disease showed no benefit of a beta-secretase enzyme inhibitor over placebo and a potential signal of worse cognitive test scores over 3 and 6 months.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据